Mozart Therapeutics, Inc
Mozart Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, WA, focused on developing innovative therapies aimed at restoring immune system function in patients suffering from autoimmune diseases. Their pioneering approach involves first-in-class CD8 Treg modulators that target the underlying causes of immune surveillance dysregulation to achieve durable immune homeostasis.
Building on significant research by Professor Mark Davis, Mozart is advancing a pipeline of novel biologics designed to address CD8 Treg dysfunction. These therapies aim to mitigate progressive inflammation and tissue damage associated with pathogenic autoimmune responses.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.



